Review of microbiota-informed approaches for adolescent depression notes limited causal evidence

Photo by Robina Weermeijer / Unsplash

Frontiers in Medicine Published May 26, 2026 Medically reviewed May 26, 2026 Study authors: Yimin Shi, Qian Ma DOI ↗ By Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease

Key Takeaway

Note that microbiota-informed approaches are adjunctive only and lack established standalone efficacy for adolescent depression.

This narrative review explores the potential of microbiota-informed approaches for managing adolescent depression. The scope includes dual-sensitive period gut-brain crosstalk, neuroinflammation, microbiota-gut-brain axis perturbations, diet, antibiotics, sleep disruption, psychobiotics, and dietary optimization. The authors do not report a specific sample size or follow-up duration for the primary data synthesized. Instead, the text aggregates qualitative arguments regarding the biological plausibility and preliminary clinical observations associated with these factors.

The authors conclude that psychobiotics, dietary optimization, and related microbiota-informed approaches may hold promise as adjunctive or preventive strategies. However, the review explicitly states that these methods are not yet established standalone treatments for adolescent depression. The text highlights that direct causal evidence in adolescents remains limited, which is a primary limitation acknowledged by the authors.

The review does not report specific adverse events, tolerability data, or discontinuation rates. Consequently, safety profiles for these interventions are not detailed in the source material. Clinicians should interpret these findings with caution, recognizing that the evidence base is currently observational and lacks the robustness required for standalone therapeutic recommendations.

Study Details

Study typeSystematic review

EvidenceLevel 1

PublishedMay 2026

View Original Abstract ↓

The increasing burden of adolescent depression underscores the need to identify developmental vulnerabilities and biologically informed strategies for prevention and intervention. This review synthesizes evidence supporting adolescence as a “dual-sensitive period” during which concurrent maturation of the brain and gut microbiota may create a window of susceptibility to perturbations of the microbiota–gut–brain axis (MGBA). During this stage, dysregulated gut–brain communication may contribute to low-grade inflammation, impaired barrier function, altered HPA-axis responsivity, and changes in tryptophan-, short-chain fatty acid-, and neurotransmitter-related metabolism. In particular, inflammatory signaling and microglial activation may link gut dysbiosis to maladaptive synaptic remodeling, although direct causal evidence in adolescents remains limited. The review also examines the “microgenderome” framework as a lens for understanding potential sex-related differences in depression, and considers environmental exposures such as diet, antibiotics, and sleep disruption as perturbing influences on MGBA homeostasis. Translationally, psychobiotics, dietary optimization, and related microbiota-informed approaches may hold promise as adjunctive or preventive strategies, but they are not yet established standalone treatments for adolescent depression. Future studies integrating longitudinal design, multi-omics profiling, biomarkers, and adolescent-specific intervention trials will be essential to clarify causality and guide precision prevention.